What do we do
is a small consultancy firm with a broad experience in early and late phase CMC development. Maggres-pharma has been started with the aim of bringing new translational medicine to the market; to help you make big steps in your pharmaceutical development.
are nowadays primarily resulting from small biotechnology companies, often university spin-offs, which are highly specialized in specific areas of research. A brilliant idea leads to the discovery of a potentially translational medicine, meeting actual patients needs. However the company subsequently falters translating the brilliant, bench top, idea into a viable pharmaceutical product due to lack of development experience and pharmaceutical mindset. This can lead to an increased time to market or worse, the translational medicine may never even make it to the patient!
This is the need that Maggres-pharma intends to address; we have a
strong track record
of supporting small and large biotechnologies in their pharamceutical development; main areas of expertise are all activities associated with Chemistry, Manufacturing and Control:
Clinical GMP Manufacturing
Quality and Compliance
Regulatory Filing and Support
Selection and Management of your Contract Development and Manufacturing Organizations
Licensing, acquisition and option deals
aims to support you in all of these areas and we are very flexible to fit with your own strengths and weaknesses. As a small company we can easily tailor our approach to what is needed to help you be successful and we look forward to help you make the
to bring your product to market.